Skip to main content
Log in

Expression of 17β-Hydroxysteroid Dehydrogenase Type 5 in Human Ovary: A Pilot Study

  • Original Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

Conversion of androstenedione to testosterone, the most potent androgen secreted by the ovary, is carried out by androgenic 17β-hydroxysteroid dehydrogenase (17β-HSD) activity. The molecular basis for this is unclear. We tested the hypothesis that type 5 17β-HSD (17β-HSD5) is responsible for testosterone formation from androstenedione in the human ovary.

Methods

We used primers specific for each type of 17β-HSD to identify quantitatively and directly sequence the polymerase chain reaction products of a human ovary library.

Results

17β-HSD1, 17β-HSD4, and 17β-HSD5 were detected in the library lysate, but not 17β-HSD2 or 17β-HSD3. 17β-HSD5 was the predominant androgenic form of 17β-HSD expressed in human ovary.

Conclusion

These data suggest that 17β-HSD5 may play a major role in testosterone biosynthesis by the human ovary. Further investigation of the regulation of 17β-HSD5 gene expression is warranted with regard to ovarian testosterone secretion in normal and abnormal states of ovarian function, such as polycystic ovary syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Labrie F, Luu-The V, Lin SX, et al. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148–58.

    Article  CAS  Google Scholar 

  2. Peltoketo H, Isomaa V, Maentausta O, et al. Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 1988;239:73–7.

    Article  CAS  Google Scholar 

  3. The VL, Labrie C, Zhao MF, et al. Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: Evidence of two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol 1989;3:1301–9.

    Article  Google Scholar 

  4. Wu L, Einstein M, Geissler WM, et al. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem 1993;268:12964–9.

    CAS  PubMed  Google Scholar 

  5. Casey ML, MacDonald PC, Andersson S. 17 beta-Hydroxy-steroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 1994;94:2135–41.

    Article  CAS  Google Scholar 

  6. Mendonca B, Arnhold I, Bloise W, et al. 17β-Hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999;84:802–4.

    CAS  PubMed  Google Scholar 

  7. Geissler WM, Davis DL, Wu L, et al. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 1994;7:34–9.

    Article  CAS  Google Scholar 

  8. Stoffel-Wagner B, Watzka M, Steckelbroeck S, et al. Expression of 17 beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J Endocrinol 1999;160:119–26.

    Article  CAS  Google Scholar 

  9. Zhang Y, Word RA, Fesmire S, et al. Human ovarian expression of 17 beta-hydroxysteroid dehydrogenase types 1,2, and 3. J Clin Endocrinol Metab 1996;81:3594–8.

    CAS  PubMed  Google Scholar 

  10. Adamski J, Normand T, Leenders F, et al. Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem J 1995;311:437–43.

    Article  CAS  Google Scholar 

  11. Dufort I, Rheault P, Huang XF, et al. Characteristics of a highly labile human type 5 17 beta-hydroxysteroid dehydrogenase. Endocrinology 1999;140:568–74.

    Article  CAS  Google Scholar 

  12. Khanna M, Qin K, Wang RW, et al. Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases. J Biol Chem 1995;270:20162–8.

    Article  CAS  Google Scholar 

  13. Lin HK, Jez JM, Schlegel BP, et al. Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution. Mol Endocrinol 1997;11:1971–84.

    CAS  PubMed  Google Scholar 

  14. Qin K, New MI, Cheng KC. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 1993;46:673–9.

    Article  CAS  Google Scholar 

  15. Qin K, Khanna M, Cheng KC. Structure of a gene coding for human dihydrodiol dehydrogenase/bile acid-binding protein. Gene 1994;149:357–61.

    Article  CAS  Google Scholar 

  16. Adashi EY, Hennebold JD. Single-gene mutations resulting in reproductive dysfunction in women. N Engl J Med 1999;340:709–18.

    Article  CAS  Google Scholar 

  17. Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 1993;90:11312–6.

    Article  CAS  Google Scholar 

  18. Horton R, Tait JF. Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest 1966;45:301–13.

    Article  CAS  Google Scholar 

  19. Bardin C, Lipsett M. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 1967;46:891–902.

    Article  CAS  Google Scholar 

  20. Kirschner MA, Sinhamahapatra S, Zucker IR, et al. The production, origin and role of dehydroepiandrosterone and D5-androstenediol as androgen prehormones in hirsute women. J Clin Endocrinol Metab 1973;37:183–9.

    Article  CAS  Google Scholar 

  21. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322–53.

    Article  CAS  Google Scholar 

  22. Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hypcrandrogenism. J Clin Endocrinol Metab 1994;79:1686–92.

    CAS  PubMed  Google Scholar 

  23. Pittaway DE, Andersen RN, Coleman SA Jr, et al. Human ovarian 17 beta-hydroxysteroid oxidoreductase activity: A comparison of normal and polycystic ovarian tissues. J Clin Endocrinol Metab 1983;56:715–29.

    Article  CAS  Google Scholar 

  24. Barbieri R. Human ovarian 17-ketosteroid oxidoreductase: Unique characteristics of the granulosa-luteal cell and stromal enzyme. Am J Obstet Gynecol 1992;166:1117–23.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert L. Rosenfield MD.

Additional information

This work was supported by USPHS grant no. T32 DK-07011, a gift from Lilly Research Laboratories (KQ), and USPHS grant nos. HD-06308 and RR-00055 (RLR).

The authors thank Dr. Samuel Refetoff for helpful advice.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qin, Kn., Rosenfield, R.L. Expression of 17β-Hydroxysteroid Dehydrogenase Type 5 in Human Ovary: A Pilot Study. Reprod. Sci. 7, 61–64 (2000). https://doi.org/10.1177/107155760000700109

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/107155760000700109

Key words

Navigation